Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Wockhardt Limited (NSE: WOCKPHARMA), ISIN INE049B01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
WOCKPHARMA last traded at ₹2030.00 (+4.26%), with a 52-week range of ₹1086.70 to ₹2422.30 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 49.32%, FIIs 7.02%, DIIs 9.00%, mutual funds 5.99%.
EquiSense Score (ECS): 53/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.